^
    over2years
    Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia (clinicaltrials.gov)
    P1, N=10, Not yet recruiting, iCell Gene Therapeutics
    New P1 trial • CAR T-Cell Therapy
    |
    CD33 (CD33 Molecule)
    |
    CD33 positive
    |
    ICG165